Skip to main content
. 2020;21(2):491–498. doi: 10.31557/APJCP.2020.21.2.491

Figure 1.

Figure 1

Circulating miR-155 Expression Levels in Breast Cancer Patients were Frequently Upregulated and were Significantly Higher Compared to Healthy Women. Medians of miR-155 expression levels were 18.49±19 and 1.28±0.18, respectively; p<0.0001